Head-to-head comparison of palbociclib and ribociclib in first-line treatment of HR-positive/HER2-negative metastatic breast cancer with real-world data from the OPAL registry
基于OPAL注册研究的真实世界数据,对帕博西尼和瑞博西尼一线治疗HR阳性/HER2阴性转移性乳腺癌的疗效进行头对头比较。
期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.35296
Thill, Marc; Zahn, Mark-Oliver; Welt, Anja; Nusch, Arnd; Zaiss, Matthias; Engelken, Kathrin; Kaltenecker, Gabriele; Ringwald, Kai; Gratzke, Katja; Dille, Stephanie; Kruggel, Lisa; Jänicke, Martina; Schulz, Holger; Hagen, Volker; Fricker, Roland; Stickeler, Elmar; Harbeck, Nadia; Wöckel, Achim; Decker, Thomas